WELL Health announced that its technology subsidiary, WELLSTAR, has secured $62M in growth financing ahead of its planned spin-out and public listing, expected in 2026. The financing will fund organic growth, AI innovation, and targeted acquisitions as WELLSTAR positions itself as a pure-play healthcare SaaS provider. The transaction follows an earlier $50.4M round completed in late 2024 that funded two tuck-in acquisitions and the initial formation of WELLSTAR as a separate operating entity. Together, these financings equip WELLSTAR with a robust capital base to execute its expansion strategy ahead of its debut as an independent public company. This financing values WELLSTAR at approximately $535M, post-money.